Pages that link to "Q33813212"
Jump to navigation
Jump to search
The following pages link to Association of structural changes in the V2 and V3 loops of the gp120 envelope glycoprotein with acquisition of neutralization resistance in a simian-human immunodeficiency virus passaged in vivo (Q33813212):
Displaying 38 items.
- Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch (Q24672335) (← links)
- Structure and receptor binding preferences of recombinant human A(H3N2) virus hemagglutinins (Q27697647) (← links)
- Mutations in HIV-1 envelope that enhance entry with the macaque CD4 receptor alter antibody recognition by disrupting quaternary interactions within the trimer. (Q30368471) (← links)
- A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12. (Q31143293) (← links)
- R5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate models (Q33640144) (← links)
- Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif (Q33717525) (← links)
- Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys (Q33839485) (← links)
- Feline immunodeficiency virus-infected cat sera associated with the development of broad neutralization resistance in vivo drive similar reversions in vitro (Q33854938) (← links)
- The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner (Q33883936) (← links)
- The role of the third beta strand in gp120 conformation and neutralization sensitivity of the HIV-1 primary isolate DH012 (Q33953062) (← links)
- Molecular evolution of human immunodeficiency virus env in humans and monkeys: similar patterns occur during natural disease progression or rapid virus passage (Q34338411) (← links)
- Mutagenic stabilization and/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein (Q34347265) (← links)
- Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. (Q34349343) (← links)
- Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins (Q34465007) (← links)
- The evolving role of information technology in the drug discovery process (Q34537685) (← links)
- A Conserved Determinant in the V1 Loop of HIV-1 Modulates the V3 Loop To Prime Low CD4 Use and Macrophage Infection (Q34741807) (← links)
- Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes (Q35034268) (← links)
- Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor (Q36509765) (← links)
- Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses (Q36673173) (← links)
- R5X4 viruses are evolutionary, functional, and antigenic intermediates in the pathway of a simian-human immunodeficiency virus coreceptor switch (Q36747765) (← links)
- Cross-neutralization between three mumps viruses & mapping of haemagglutinin-neuraminidase (HN) epitopes (Q36769692) (← links)
- HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds (Q37073506) (← links)
- Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus (Q37682968) (← links)
- Germline-targeting immunogens (Q38764547) (← links)
- Efficiency of Neutralizing Antibodies Targeting the CD4-Binding Site: Influence of Conformational Masking by the V2 Loop in R5-Tropic Clade C Simian-Human Immunodeficiency Virus (Q38961133) (← links)
- The HIV-1 repeated sequence R as a robust hot-spot for copy-choice recombination (Q39099158) (← links)
- Addition of a single gp120 glycan confers increased binding to dendritic cell-specific ICAM-3-grabbing nonintegrin and neutralization escape to human immunodeficiency virus type 1. (Q39193318) (← links)
- Properties of the surface envelope glycoprotein associated with virulence of simian-human immunodeficiency virus SHIV(SF33A) molecular clones (Q39682485) (← links)
- Introduction of exogenous epitopes in the variable regions of the human immunodeficiency virus type 1 envelope glycoprotein: effect on viral infectivity and the neutralization phenotype (Q39843176) (← links)
- Evolution of coreceptor use and CD4-independence in envelope clones derived from SIVsm-infected macaques (Q40619758) (← links)
- HIV-1 ENVELOPE. Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein (Q41138686) (← links)
- Mutation at a single position in the V2 domain of the HIV-1 envelope protein confers neutralization sensitivity to a highly neutralization-resistant virus (Q41844960) (← links)
- Genome exploration of six variants of the Ostreid Herpesvirus 1 and characterization of large deletion in OsHV-1μVar specimens (Q42268311) (← links)
- Topological analysis of HIV-1 glycoproteins expressed in situ on virus surfaces reveals tighter packing but greater conformational flexibility than for soluble gp120. (Q42572387) (← links)
- Effects of HIV Type 1 Envelope Glycoprotein Proteolytic Processing on Antigenicity (Q44614090) (← links)
- Evaluation of infectivity of a canine lineage H3N8 influenza A virus in ponies and in primary equine respiratory epithelial cells (Q45364575) (← links)
- The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4. (Q45662866) (← links)
- Evidence for a mechanism of recombination during reverse transcription dependent on the structure of the acceptor RNA (Q73023500) (← links)